Publicaciones en colaboración con investigadores/as de Hospital Miguel Servet (41)

2024

  1. Author Correction: Effectiveness and safety of XEN63 in patients with primary-open-angle glaucoma (Scientific Reports, (2024), 14, 1, (4561), 10.1038/s41598-024-55287-z)

    Scientific Reports

  2. Chronic Glaucoma Induced in Rats by a Single Injection of Fibronectin-Loaded PLGA Microspheres: IOP-Dependent and IOP-Independent Neurodegeneration

    International Journal of Molecular Sciences, Vol. 25, Núm. 1

  3. Effectiveness and safety of XEN63 in patients with primary-open-angle glaucoma

    Scientific Reports, Vol. 14, Núm. 1

  4. Influence of sex on chronic steroid-induced glaucoma: 24-Weeks follow-up study in rats

    Experimental Eye Research, Vol. 238

  5. Multi-loaded PLGA microspheres as neuroretinal therapy in a chronic glaucoma animal model

    Drug Delivery and Translational Research

  6. XEN® 45 en el manejo quirúrgico del glaucoma en fases tempranas: estudio nacional de consenso según metodología Delphi

    Archivos de la Sociedad Española de Oftalmologia, Vol. 99, Núm. 3, pp. 98-108

2022

  1. Mimicking chronic glaucoma over 6 months with a single intracameral injection of dexamethasone/fibronectin-loaded PLGA microspheres

    Drug Delivery, Vol. 29, Núm. 1, pp. 2357-2374

2021

  1. Analysis of parainflammation in chronic glaucoma using vitreous-oct imaging

    Biomedicines, Vol. 9, Núm. 12

  2. Influence of sex on neuroretinal degeneration: Six-month follow-up in rats with chronic glaucoma

    Investigative Ophthalmology and Visual Science, Vol. 62, Núm. 13

  3. Long-term corticosteroid-induced chronic glaucoma model produced by intracameral injection of dexamethasone-loaded PLGA microspheres

    Drug Delivery, Vol. 28, Núm. 1, pp. 2427-2446

  4. Novel use of plga microspheres to create an animal model of glaucoma with progressive neuroretinal degeneration

    Pharmaceutics, Vol. 13, Núm. 2, pp. 1-20

2020

  1. Ocular involvement in Friedreich ataxia patients and its relationship with neurological disability, a follow-up study

    Diagnostics, Vol. 10, Núm. 2

  2. Structure-function relationship in a series of glaucoma cases

    Journal Francais d'Ophtalmologie, Vol. 43, Núm. 2, pp. 111-122

2019

  1. Changes in retinal OCT and their correlations with neurological disability in early ALS patients, a follow-up study

    Brain Sciences, Vol. 9, Núm. 12

  2. Three-Year Results of Hydrus Microstent with Phacoemulsification

    Ophthalmology. Glaucoma, Vol. 2, Núm. 6, pp. 440-442

2018

  1. Correlations between peripapillary retinal nerve fiber layer thickness and macular thickness in different various stages of primary open-angle glaucoma

    Journal Francais d'Ophtalmologie, Vol. 41, Núm. 8, pp. 725-732

  2. New normative database of inner macular layer thickness measured by spectralis OCT used as reference standard for Glaucoma Detection

    Translational Vision Science and Technology, Vol. 7, Núm. 1

  3. Ocular Redness Measured with the Keratograph 5M in Patients Using Anti-Glaucoma Eye Drops

    Seminars in Ophthalmology, Vol. 33, Núm. 5, pp. 643-650

  4. Redefiniendo la cirugía de glaucoma mínimamente invasiva. Cirugía mínimamente penetrante

    Archivos de la Sociedad Española de Oftalmologia, Vol. 93, Núm. 4, pp. 157-159

2017

  1. Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma

    Advances in Therapy, Vol. 34, Núm. 2, pp. 378-395